Sector Watch: Healthcare - Apr 01 2019
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $111.91 +0.11 0.1% | XBI: $90.43 -0.11 -0.12% | Updated Apr 01, 2019 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| AVEO AVEO Pharmaceuticals $154.3M |
1.11+0.29 30.7 M 5.5x |
35% | ||
| ATNM Actinium Pharmaceuticals $71.5M |
0.60+0.12 1.5 M |
25% | ||
| CVM Cel-Sci $120.9M |
4.06+0.52 2.1 M 6.8x |
15% | ||
| AAC AAC Holdings $51.9M |
2.11+0.27 303.4 K |
15% | ||
| CBIO Catalyst Biosciences $106.9M |
8.93+0.82 429.6 K 2.4x |
10% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| AKTX Akari Therapeutics $4.9B |
3.18-0.40 414.1 K |
-11% | ||
| SRNE Sorrento Therapeutics $519.7M |
4.25-0.50 2.9 M |
-11% | ||
| NSPR52WH InspireMD $267.7M |
6.39-0.61 360.7 K |
-9% | ||
| MNKD MannKind $338.0M |
1.80-0.17 6.0 M |
-9% | ||
| IMMU Immunomedics $3.4B |
17.59-1.62 6.3 M 2.6x |
-8% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2019 - ResearchAndMarkets.com | Business Wire [businesswire.com]Catalyst Biosciences Receives Orphan Designation from the European Commission for Marzeptacog Alfa (Activated) [globenewswire.com]
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of UXIN, AVEO, AMR and UMC [globenewswire.com]
Maryland Chamber of Commerce ?Inspire MD? Event Shapes Up to Be Night True to Its Name [globenewswire.com]
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LXRX, UXIN, AVEO and AMRN [globenewswire.com]
Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC [globenewswire.com]
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vanda Pharmaceuticals, AVEO Pharmaceuticals, Stamps.com, and Syneos and Encourages Investors to Contact the Firm [globenewswire.com]
Akari Therapeutics to Provide Update on its Eye Disease Program During Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting [globenewswire.com]
CLASS ACTION UPDATE for UXIN, AVEO, AMRN and AMR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [globenewswire.com]
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors to Contact the Firm [globenewswire.com]
Scilex Holding, a Subsidiary of Sorrento Therapeutics, Announces Phase 2 Trial Results for its Leading SP-102 Program - GlobeNewswire (20 visits) [globenewswire.com]
AVEO: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against AVEO Pharmaceuticals Inc.? AVEO - GlobeNewswire [globenewswire.com]
InspireMD Announces 1-for-50 Reverse Stock Split [globenewswire.com]
InspireMD Provides Amended Disclosure [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
